Top Markets
#1 Black Phoenix Black Phoenix +195.57%
#2 Islamic Coin Islamic Coin +158.05%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +34.97%
#5 Acurast Acurast +27.36%
#6 Cryptopia Cryptopia +21.79%
#7 Quantum Resistant Ledger Quantum Resistant Ledger +17.37%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.57%
#9 Test Test +14.82%
#10 Playnance Playnance +14.01%
Coin of the day
Black Phoenix Black Phoenix
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
AmerisourceBergen Corporation AmerisourceBergen Corporation

AmerisourceBergen Corporation

ABC
Classifica tra le azioni #681
AmerisourceBergen Corporation (ABC) operates as a prominent global distributor... AmerisourceBergen Corporation (ABC) operates as a prominent global distributor and procurer of pharmaceutical products. Its core business is structured around two main segments. The Pharmaceutical Distribution division is responsible for the extensive supply of both brand-name and generic medicines, alongside over-the-counter health items, and equipment for home healthcare. This segment extends its services to a wide array of healthcare entities, including acute care hospitals, integrated health systems, independent and chain retail pharmacies, mail-order drug providers, medical clinics, and facilities offering long-term care or alternative site pharmacy services. Beyond product distribution, it offers comprehensive pharmacy management and staffing solutions, consulting expertise, and specialized supply chain software tailored for both retail and institutional healthcare settings. Furthermore, ABC provides bespoke packaging services. This division also manages the distribution of vital plasma and blood products, various injectable pharmaceuticals, vaccines, and other specialty medications. It furnishes support services primarily to physicians specializing in areas like oncology, as well as to hospitals and dialysis centers, while also delivering critical data analytics, outcomes research, and supplementary services to biotechnology and pharmaceutical manufacturers. The Other segment encompasses a range of integrated services for manufacturers, spanning clinical trial assistance, post-approval support, and commercialization strategies for new products. It also manages specialized transportation and logistics crucial for the biopharmaceutical sector. Additionally, this segment supplies pharmaceuticals, vaccines, parasiticides, diagnostic tools, and micro feed ingredients to both companion animal and production animal markets. It further aids manufacturers by providing sales force services aimed at generating demand. AmerisourceBergen Corporation was established in 2001 and maintains its headquarters in Conshohocken, Pennsylvania.
Prezzo delle azioni
$187.22
Ultima sincronizzazione: 2023-09-25
Capitalizzazione di mercato
$37.88B
Variazione (1 giorno)
0.68%
Variazione (1 anno)
0.00%
Paese
US
Scambia AmerisourceBergen Corporation (ABC)

Categoria

Healthcare
Rapporto P/E per AmerisourceBergen Corporation (ABC)
Rapporto P/E al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di AmerisourceBergen Corporation, il rapporto P/E attuale (TTM) è 0. Alla fine del 2026, il rapporto P/E era 0.
Storico del rapporto P/E per AmerisourceBergen Corporation da 2026 a 2026
Rapporto P/E alla fine di ogni anno
Anno Rapporto P/E Cambia
Non abbastanza dati per le date fornite.
Rapporto P/E per aziende simili o concorrenti
Azienda P/E Ratio Differenza del P/E Ratio Il paese
McKesson Corporation McKesson Corporation
McKesson Corporation
MCK.US
 22.16 -
US
Cencora, Inc. Cencora, Inc.
Cencora, Inc.
COR.US
 - -
US
Cardinal Health, Inc. Cardinal Health, Inc.
Cardinal Health, Inc.
CAH.US
 35.07 -
US
Sigma Healthcare Limited Sigma Healthcare Limited
Sigma Healthcare Limited
SIG.AX
 134.86 -
AU
Henry Schein, Inc. Henry Schein, Inc.
Henry Schein, Inc.
HSIC.US
 25.67 -
US
Come leggere un P/E ratio?

Il rapporto Prezzo/Utile (P/E) misura la relazione tra il prezzo delle azioni di una società e i suoi utili per azione.
Un P/E basso ma positivo indica un'azienda che genera alti profitti rispetto alla sua valutazione attuale e potrebbe essere sottovalutata. Un'azienda con un P/E negativo elevato (vicino allo 0) segnala forti perdite rispetto alla valutazione.

Le aziende con un P/E superiore a 30 o negativo sono generalmente considerate "azioni di crescita", cioè ci si aspetta che crescano o diventino redditizie.

Le aziende con un P/E positivo inferiore a 10 sono considerate "azioni di valore", ossia già molto redditizie ma con scarse prospettive di crescita.